Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00OUF
|
||||
| Former ID |
DNC013448
|
||||
| Drug Name |
1-(3-phenoxypropyl)-4-(piperidin-1-yl)piperidine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H30N2O
|
||||
| Canonical SMILES |
C1CCN(CC1)C2CCN(CC2)CCCOC3=CC=CC=C3
|
||||
| InChI |
1S/C19H30N2O/c1-3-8-19(9-4-1)22-17-7-12-20-15-10-18(11-16-20)21-13-5-2-6-14-21/h1,3-4,8-9,18H,2,5-7,10-17H2
|
||||
| InChIKey |
GCJKCPQHXFIKIF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | (S)-reticuline biosynthesis | ||||
| Eumelanin biosynthesis | |||||
| L-dopachrome biosynthesis | |||||
| KEGG Pathway | Tyrosine metabolism | ||||
| Riboflavin metabolism | |||||
| Metabolic pathways | |||||
| Melanogenesis | |||||
| PathWhiz Pathway | Riboflavin Metabolism | ||||
| Tyrosine Metabolism | |||||
| WikiPathways | Dopamine metabolism | ||||
| References | |||||
| REF 1 | Eur J Med Chem. 2007 Nov-Dec;42(11-12):1370-81. Epub 2007 Feb 23.Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.